Electrical Contracting for Pharmaceutical & Life Sciences

Electrical Contracting for Pharmaceutical & Life Sciences

Electrical contracting in pharmaceutical and life sciences facilities is not a generic “build-to-print” activity. It is a tightly controlled engineering service that must support product quality, operator safety, data integrity, uptime, and regulatory compliance across cleanrooms, laboratories, utilities, packaging lines, warehouses, and critical infrastructure. In practice, the contractor is expected to deliver not only installed power and control systems, but also a traceable, testable, and validated electrical scope that fits the facility’s quality system and commissioning strategy.

How the Scope Is Defined

For this sector, scope definition usually starts with a user requirements specification (URS), then flows into basis of design, detailed design, installation, testing, and qualification. Electrical contracting packages commonly include LV distribution, MCCs, panel boards, UPS systems, generators, earthing and bonding, cleanroom lighting, process equipment power, instrumentation cabling, fiber and structured cabling, and interfaces to BMS/EMS/SCADA systems.

The key difference from general industrial work is that the contractor must protect controlled environments and critical processes. That means the scope often includes shutdown planning, contamination control, segregated routing, temporary power, and strict change management. In EU projects, this is frequently aligned with the customer’s validation master plan and, where applicable, GMP expectations under EudraLex Volume 4. For machinery interfaces, electrical design and installation must also support compliance with the EU Machinery framework and the technical requirements typically demonstrated through IEC/EN standards.

Typical deliverables

• Single-line diagrams, load schedules, and panel schedules
• Equipment layouts, cable routing drawings, and containment details
• Earthing and bonding calculations and drawings
• Cause-and-effect matrices for critical shutdowns and interlocks
• Test plans, inspection checklists, and as-built documentation
• O&M manuals, spares lists, and asset registers
• Commissioning and qualification records, including FAT/SAT evidence

Applicable Standards and Compliance Drivers

Pharmaceutical and life sciences projects often span multiple standards families. The electrical contractor must know which standard governs which part of the installation. For low-voltage assemblies, IEC 61439 is central for type-tested or design-verified assemblies, with IEC 61439-1 covering general rules and IEC 61439-2 covering power switchgear and controlgear assemblies. For electrical installations in buildings, IEC 60364 and its national adoptions, such as EN 60364, are typically the baseline. In hazardous locations, IEC 60079 series requirements may apply depending on the process area classification.

For machinery-related electrical work, IEC 60204-1 is especially important. Clause 4 addresses general requirements, Clause 5 covers incoming supply disconnecting means, Clause 7 covers protection of equipment, Clause 8 addresses equipotential bonding, and Clause 18 covers verification. In North American projects, NFPA 70 (NEC) Article 110 governs general requirements for electrical installations, while Article 517 is often relevant in healthcare environments. For industrial control panels, UL 508A is commonly used in the U.S. market, while IEC/EN conformity is more common in Europe. For functional safety, IEC 61508 and IEC 62061 may be relevant, and ISA 84 / IEC 61511 applies where safety instrumented functions are part of process utilities or containment systems.

Cybersecurity is increasingly part of the electrical scope when panels, PLCs, drives, and remote I/O are networked. In EU contexts, NIS2 obligations may drive stronger asset inventory, access control, patching, and incident response requirements, especially where the facility is part of critical supply chains. Electrical contractors are not usually the owner of cyber governance, but they are often responsible for secure cabinet access, password handling procedures, network segregation, and documentation of connected assets.

How the Work Is Delivered

Delivery usually follows a staged model: survey and constructability review, detailed engineering, procurement, installation, pre-commissioning, commissioning, and handover. In regulated facilities, the contractor must preserve traceability between design intent and installed condition. That means cable tags, ferruling, panel modifications, and software-backed controls must match approved documents. Deviations are handled through formal change control, not informal field fixes.

Commissioning is not the same as validation, but the two must be coordinated. Commissioning verifies that the electrical system is installed correctly and functions as intended. Validation demonstrates that the system supports the intended use and quality requirements under defined operating conditions. A good contractor understands where commissioning ends and qualification begins, and provides clean test evidence that can be reused by the client’s validation team.

Typical tests include continuity, insulation resistance, polarity, earth fault loop verification, functional checks, protective device coordination checks, and rotation tests on motors and pumps. For critical power systems, load bank testing, transfer tests, and autonomy checks for UPS systems are common. For life sciences utilities, the contractor may also support monitoring of voltage quality, harmonics, and transient performance to protect sensitive instruments and control systems.

Common Engineering Decisions

Several decisions have outsized impact on cost, compliance, and reliability. One is whether to use centralized or distributed control power architecture. Another is whether to specify copper or aluminum conductors in large feeders. A third is how to separate clean utilities, process loads, IT/OT networks, and emergency systems.

Decision	Preferred in Life Sciences	Why it matters
Centralized vs distributed panels	Often distributed for process areas	Shorter cable runs, easier segregation, better maintainability
UPS autonomy	Defined by criticality, often 15–60 minutes	Supports controlled shutdown, alarms, and ride-through
Earthing strategy	Low-impedance, well-bonded network	Reduces touch voltage and improves EMC performance
Network segmentation	Strict IT/OT separation	Supports cybersecurity and limits fault propagation

One practical calculation used early in design is feeder sizing and voltage drop. For a three-phase feeder, a simplified estimate is:

$$\Delta V \approx \sqrt{3} \cdot I \cdot R \cdot L$$

where $I$ is current, $R$ is conductor resistance per unit length, and $L$ is one-way length. In pharmaceutical facilities, voltage drop is not just a utility issue; it can affect VFD performance, cleanroom AHUs, refrigeration, and process skids. Designers typically keep this within the project’s specified limits, often more conservative than the minimum code requirement.

Validation and Handover

Validation-ready handover is a hallmark of competent pharmaceutical electrical contracting. The contractor should deliver redlines, as-builts, test packs, certificates, calibration references where applicable, and a full asset list. Where the electrical system supports regulated processes, the handover package should help the client demonstrate traceability, repeatability, and control. This is especially important for utilities feeding sterilization, purified water systems, environmental monitoring, and cold-chain storage.

In short, the best electrical contracting teams in this sector do more than install cables and panels. They build compliant infrastructure that can survive audit scrutiny, support qualification, and remain maintainable over the facility lifecycle. If you are planning a new build, expansion, or retrofit in pharma or life sciences, discuss your project via /contact.